The World Health Organization is now recommending that countries include a newly approved HIV drug for prevention, lenacapavir, as a tool in their efforts to fight HIV infections, especially for groups most at risk and in areas where the burden of HIV remains high.This landmark guidance, released at the 13th International AIDS Society Conference in Kigali on July 14 – …
Read More »WHO recommends Gilead’s twice-yearly injection for HIV prevention Reuters WHO recommends twice-a-year HIV prevention shot as concern looms over funding for global HIV fight CNN Guidelines on lenacapavir for HIV prevention and testing strategies for long-acting injectable pre-exposure prophylaxis World Health Organization (WHO) Gilead to provide HIV prevention drug to 2 million people in lower-income countries at cost STAT WHO urges rollout of first …
Read More »
The World Health Organization (WHO) released today new guidelines recommending the use of injectable lenacapavir (LEN) twice a year as an additional pre-exposure prophylaxis (PrEP) option for HIV prevention, in a landmark policy action that could help reshape the global HIV response. The guidelines are being issued at the 13th International AIDS Society Conference (IAS 2025) on HIV Science, in Kigali, …
Read More »
Facebook Tweet Email Link The World Health Organization is now recommending that countries include an HIV drug newly approved for prevention, lenacapavir, as a tool in their efforts to fight HIV infections – especially for groups most at risk and in areas where the burden of HIV remains high. The global recommendation – issued Monday at the International AIDS Conference …
Read More »